| HOME >> MEDICINE >> TECHNOLOGY |
$
,904.1$
2,874.1 Accounts payable
2,020.5928.1 Accrued expenses
1,989.9656.0 Short term loan payable
1,039.6- Current maturities of long-term debt
889.7999.9Total current liabilities
12,843.85,458.1 Long-term debt
16,312.37,076.4 Other liabilities
6,774.1598.8Total liabilities
35,930.213,133.3 Stockholders' Equity: Preferred stock, 15.0 shares authorized, $0.01 par value per share and no shares issued and outstanding
-- Common stock, 2,985.0 shares authorized, $0.01 par value per share shares issued: 809.6 and 690.7, respectively; shares outstanding: 809.6 and 484.6, respectively
8.16.9 Additional paid-in capital
20,918.12,438.2 Accumulated other comprehensive income
8.117.0 Retained earnings
1,194.06,645.622,128.39,107.7 Common stock in treasury at cost, zero and 206.1 shares, respectively
-(6,634.0)Total stockholders' equity
22,128.32,473.7Total liabilities and stockholders' equity
$ 58,058.5$
5,607.0 EXPRESS SCRIPTS Unaudited Consolidated Statement of Cash Flows Six Months Ended
June 30, (in millions) 20122011 Cash flows from operating activities: Net income$
438.7$
.7 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization
670.2126.2 Non-cash adjustments to net income
95.6124.4 Deferred financing fees
26.92.4 Changes in operating assets and liabilities, net of effects of a
'/>"/>
| SOURCE Express Scripts Copyright©2012 PR Newswire. All rights reserved |